Talk:Sugammadex
From Wikipedia, the free encyclopedia
[edit] Phase III data
Any preliminary phase 3 data available for sharing? Mdw346 15:33, 7 December 2006 (UTC)MDW 07 Dec.06
Sept 16, 2007: —Preceding unsigned comment added by Mdw346 (talk • contribs) 12:01, 16 September 2007 (UTC) Preliminary Phase III and updated Phase II data has been released in Europe June 9-12, 2007 at the European Society of Anaesthesiology Munich, Germany. No surprises- continued successful, effective, dose-dependent fast time to reversal of all levels of neuromuscular blockade induced by rocuronium and vecuronium. Shallow level blockade induced by pancuronium was effectively conducted by Decoopman M, et al. Referenced in "sugammade" wiki article. Pediatric, elderly, cardiac disease, pulmonary disease, and renal disease patients also successfully treated with sugammadex (ESA mtg. June 2007. ASA mtg. October 2007). Concerns of QTc prolongation by sugammadex addressed by de Kam PJ, et al (Single IV sugammadex doses up to 32 mg/kg are not associated with QT/QTc prolongation. Anesthesiology 2007;107:A1580)The authors concluded sugammadex did not prolong the QT interval based on ICH-E14 guideline criteria.
[edit] Selective Relaxant Binding Agent
Started a wiki subject page "Selective Relaxant Binding Agent"[1] and a discussion page. It could use help and maybe a link from "SRBA" in this article. Good idea? Thoughts? —Preceding unsigned comment added by Mdw346 (talk • contribs) 12:40, 16 September 2007 (UTC)
[edit] WikiProject class rating
This article was automatically assessed because at least one WikiProject had rated the article as start, and the rating on other projects was brought up to start class. BetacommandBot 16:31, 10 November 2007 (UTC)

